In the COVID-19 pandemic era, at-home, portable tests were crucial for knowing when to wear a mask or isolate at home. Now, ...

A new experimental vaccine developed by researchers at MIT and Caltech could offer protection against emerging variants of SARS-CoV-2, as well as related coronaviruses, known as sarbecoviruses, that ...

Researchers report the ability of tofacitinib to reduce infection risk with SARS-CoV-2 in individuals who are deficient in ...

Investigators from Mass General Brigham​ have found that a method originally designed for cancer detection can also identify and monitor even tiny amounts of SARS-CoV-2 intact viral particles in blood ...

Nearly one in 20 people who had a SARS-CoV-2 infection go on to experience myalgic encephalomyelitis/chronic fatigue syndrome ...

MIT and Caltech scientists designed a new vaccine targeting stable virus regions to protect against various coronavirus strains.

The following is a summary of “Multiplex lateral flow test sensitivity and specificity in detecting influenza A, B and ...

Two-thirds of people with post-COVID-19 syndrome have persistent, objective symptoms—including reduced physical exercise capacity and reduced cognitive test performances—for a year or more, with no ...

Senate Majority Leader John Thune had called out Democratic Connecticut Sen. Chris Murphy for delaying the vote on a “key national security position.” ...

A research team from Queen’s University Belfast has mapped the introduction and spread of the SARS-CoV-2 virus across Ireland ...

Although numerous studies have shown men have more severe acute COVID cases and higher mortality than women, females in their 40s have up to a 45% higher risk of getting long COVID than men, according ...